Found 82 Enz. Inhib. hit(s) with Target = 'Protein tyrosine phosphatase type IVA 3' TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 18nMAssay Description:The in vitro biochemical evaluation of all compounds was carried out using recombinant human PTP4A3, overexpressed as a His6-tag fusion protein in E....More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 20nMAssay Description:Inhibition of recombinant human His6-tagged PRL-3 expressed in Escherichia coli using DiFMUP as substrate incubated for 30 mins by fluorescence based...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 30nMAssay Description:Inhibition of recombinant human His-6-tagged PTP4A3 expressed in Escherichia coli assessed as reduction in hydrolysis using DIFMUP as substrate incub...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 35nMAssay Description:Inhibition of recombinant human His-6-tagged PTP4A3 expressed in Escherichia coli assessed as reduction in hydrolysis using DIFMUP as substrate incub...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 84nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 107nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 128nMAssay Description:Inhibition of full length human fusion His6 tagged PRL3 expressed in Escherichia coli using TAMRA-Thr-Ala-Asp-Ile-Tyr(PO3H2)-Glu-NH2 substrate by imm...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant human His-6-tagged PTP4A3 expressed in Escherichia coli assessed as increase in polarization using TAMRAThr-Ala-Asp-Ile-Tyr...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 132nMAssay Description:The in vitro biochemical evaluation of all compounds was carried out using recombinant human PTP4A3, overexpressed as a His6-tag fusion protein in E....More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 206nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 240nMAssay Description:Inhibition of PRL3 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 300nMAssay Description:Inhibition of PTP4A3 (unknown origin)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 460nMAssay Description:Inhibition of full-length human heart His6-tagged PRL-3 expressed in Escherichia coli using DiFMUP as substrate incubated for 35 mins by fluorescence...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 800nMAssay Description:Inhibition of human His6-tagged full length PRL3 assessed as inhibition of DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 900nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 900nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human His6-tagged full length PRL3 assessed as inhibition of DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.92E+3nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of PRL3 after 1 hr by DiFMUP assayMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 4.93E+3nMAssay Description:Inhibition of human PTP4A3 by enzyme assayMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 4.98E+3nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 6.59E+3nMAssay Description:Inhibition of recombinant human PTP4A3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of human recombinant PRL-3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of PRL3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.33E+4nMAssay Description:Inhibition of recombinant human PTP4A3 expressed in Escherichia coli BL21 (DE3) assessed as reduction in hydrolysis using DIFMUP as substrate incubat...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.33E+4nMAssay Description:Inhibition of human PRL3 expressed in Escherichia coli BL21 (DE3)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.52E+4nMAssay Description:Inhibition of PRL-3 (unknown origin) using DiFMUP as substrate incubated for 1 hrMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.54E+4nMAssay Description:Inhibition of human PRL3 expressed in Escherichia coli BL21 (DE3)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.54E+4nMAssay Description:Inhibition of recombinant human PTP4A3 expressed in Escherichia coli BL21 (DE3) assessed as reduction in hydrolysis using DIFMUP as substrate incubat...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.83E+4nMAssay Description:Inhibition of human PRL3 expressed in Escherichia coli BL21 (DE3)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.83E+4nMAssay Description:Inhibition of recombinant human PTP4A3 expressed in Escherichia coli BL21 (DE3) assessed as reduction in hydrolysis using DIFMUP as substrate incubat...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of PRL-3 (unknown origin) using DiFMUP as substrate incubated for 1 hrMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.58E+4nMAssay Description:Inhibition of human brain PRL-3 (1 to 168 residues) expressed in Escherichia coli BL21(DE3) cells using DiFMUP as substrate incubated for 1 hr by flu...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of PRL-3 (unknown origin) using DiFMUP as substrate incubated for 1 hrMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.67E+4nMAssay Description:Inhibition of PRL-3 (unknown origin) using DiFMUP as substrate incubated for 1 hrMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.76E+4nMAssay Description:Inhibition of PRL3More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
University Of Virginia Patent Foundation
US Patent
University Of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.77E+4nMAssay Description:Inhibition of human PRL3 expressed in Escherichia coli BL21 (DE3)More data for this Ligand-Target Pair
